Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
RETRACTION: Role of the MUC1‐C Oncoprotein in the Acquisition of Cisplatin Resistance by Urothelial Carcinoma
RETRACTION: Role of the MUC1‐C Oncoprotein in the Acquisition of Cisplatin Resistance by Urothelial Carcinoma
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Cancer Science
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1111/cas.70016
Similar Items
RETRACTION : miR ‐25‐3p Reverses Epithelial‐Mesenchymal Transition via Targeting Sema4C in Cisplatin‐Resistance Cervical Cancer Cells
Published: (2025)
First‐In‐Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck
by: Nobuaki Matsubara, et al.
Published: (2026)
Single‐Cell RNA Sequencing Reveals the Tumor Heterogeneity and Immunosuppressive Microenvironment in Urothelial Carcinoma
by: Tianqi Lyu, et al.
Published: (2024)
Clinical Effectiveness of Tislelizumab With Gemcitabine/Cisplatin Versus Gemcitabine/Cisplatin Alone as Adjuvant Therapy for High‐Risk Muscle‐Invasive Urothelial Carcinoma: A Real‐World Study
by: Yanjun Wang, et al.
Published: (2025)
FB23 ‐2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF / ERCC1 Complex
by: Yaoqi Jiang, et al.
Published: (2026)